BR9908617A - Nitroto inorgânico e ácido orgânico em combinação como uma composição antiviral tópica. - Google Patents
Nitroto inorgânico e ácido orgânico em combinação como uma composição antiviral tópica.Info
- Publication number
- BR9908617A BR9908617A BR9908617-4A BR9908617A BR9908617A BR 9908617 A BR9908617 A BR 9908617A BR 9908617 A BR9908617 A BR 9908617A BR 9908617 A BR9908617 A BR 9908617A
- Authority
- BR
- Brazil
- Prior art keywords
- topical
- combination
- organic acid
- antiviral composition
- pharmaceutically acceptable
- Prior art date
Links
- 230000000699 topical effect Effects 0.000 title abstract 4
- 230000000840 anti-viral effect Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 150000007524 organic acids Chemical class 0.000 title abstract 2
- 150000004767 nitrides Chemical class 0.000 title 1
- MWUXSHHQAYIFBG-UHFFFAOYSA-N nitrogen oxide Inorganic materials O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 abstract 9
- 239000003814 drug Substances 0.000 abstract 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 239000002535 acidifier Substances 0.000 abstract 1
- 230000031018 biological processes and functions Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 210000002615 epidermis Anatomy 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 abstract 1
- 239000012049 topical pharmaceutical composition Substances 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9804469.6A GB9804469D0 (en) | 1998-03-02 | 1998-03-02 | Antiviral composition |
| PCT/GB1999/000605 WO1999044622A1 (en) | 1998-03-02 | 1999-03-01 | Inorganic nitrite and organic acid in combination as topical antiviral composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9908617A true BR9908617A (pt) | 2000-12-05 |
Family
ID=10827886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9908617-4A BR9908617A (pt) | 1998-03-02 | 1999-03-01 | Nitroto inorgânico e ácido orgânico em combinação como uma composição antiviral tópica. |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1059928A1 (zh) |
| JP (1) | JP2002505295A (zh) |
| KR (1) | KR20010041527A (zh) |
| CN (1) | CN1270725C (zh) |
| AU (1) | AU758264B2 (zh) |
| BR (1) | BR9908617A (zh) |
| CA (1) | CA2322199A1 (zh) |
| GB (1) | GB9804469D0 (zh) |
| HU (1) | HUP0101374A3 (zh) |
| MX (1) | MXPA00008583A (zh) |
| NO (1) | NO20004302L (zh) |
| NZ (1) | NZ506678A (zh) |
| PL (1) | PL342755A1 (zh) |
| WO (1) | WO1999044622A1 (zh) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0021317D0 (en) | 2000-08-30 | 2000-10-18 | Queen Mary & Westfield College | Transdermal pharmaceutical delivery composition |
| GB0119011D0 (en) * | 2001-08-03 | 2001-09-26 | Univ Aberdeen | Treatment of nail infections |
| WO2005007173A1 (en) | 2003-07-09 | 2005-01-27 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health | Use of nitrite salts for the treatment of cardiovascular conditions |
| US8557300B2 (en) | 2005-05-19 | 2013-10-15 | University Of Cincinnati | Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite |
| EP2124572A4 (en) | 2007-02-28 | 2012-03-28 | Invasive Animals Ltd | NITRITE SALTS USED AS PEAS IN BAITS FOR OMNIVORUS MAMMALS |
| US8932650B2 (en) * | 2011-01-11 | 2015-01-13 | Kantian Skincare LLC | Multifunctional topical formulation for the treatment of acne vulgaris and other skin conditions |
| US20130330244A1 (en) * | 2011-12-05 | 2013-12-12 | Nioxx Llc | Compositions and methods for topical nitric oxide generation |
| CA2865526C (en) | 2012-03-14 | 2020-06-23 | Novan, Inc. | Nitric oxide releasing pharmaceutical compositions |
| CN103690490B (zh) | 2012-08-23 | 2017-11-17 | 尼奥克斯(文莱)控股有限公司 | 基于微囊化化学试剂延时产生一氧化氮的系统和方法 |
| US9855211B2 (en) | 2013-02-28 | 2018-01-02 | Novan, Inc. | Topical compositions and methods of using the same |
| CN105979969B (zh) | 2013-08-08 | 2020-09-11 | 诺万公司 | 局部用组合物和使用所述组合物的方法 |
| US10322082B2 (en) | 2014-07-11 | 2019-06-18 | Novan, Inc. | Topical antiviral compositions and methods of using the same |
| EP3698775A1 (en) * | 2014-07-11 | 2020-08-26 | Novan Inc. | Topical antiviral compositions and methods of using the same |
| ITUB20154719A1 (it) | 2015-10-21 | 2017-04-21 | Glano Tech Ltd | Formulazione per il rilascio di ossido nitrico |
| JP2021515807A (ja) | 2018-03-01 | 2021-06-24 | ノーバン，インク． | 一酸化窒素放出性坐剤及びその使用の方法 |
| US10716805B2 (en) | 2018-03-19 | 2020-07-21 | Glanotech Limited | Formulation for release of nitric oxide |
| CN109437134A (zh) * | 2018-10-26 | 2019-03-08 | 中国核电工程有限公司 | 氮氧化物的制备方法及装置 |
| BR112021023632A2 (pt) | 2019-06-04 | 2022-04-19 | Thirty Respiratory Ltd | Métodos e composições para gerar óxido nítrico e usos do mesmo para entregar óxido nítrico através do trato respiratório |
| JP2023510661A (ja) | 2019-06-04 | 2023-03-15 | サーティー ホールディングス リミテッド | 窒素酸化物を生成するための方法及び組成物、並びにそれらの使用 |
| CN115884758A (zh) | 2020-04-23 | 2023-03-31 | 三十呼吸有限公司 | 用于治疗SARS-CoV和SARS-CoV-2的一氧化氮或释放一氧化氮的组合物 |
| JP2023526583A (ja) | 2020-04-23 | 2023-06-22 | サーティー レスピラトリー リミテッド | 結核を治療及び抑制するための方法及び組成物 |
| CN116617254A (zh) * | 2022-09-26 | 2023-08-22 | 杭州泽德医药科技有限公司 | 含硼酸、亚硝酸盐的抗病原微生物组合物及应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4923899A (en) * | 1987-12-22 | 1990-05-08 | Cetylite Industries, Inc. | Sterilant composition |
| MY128187A (en) * | 1993-06-23 | 2007-01-31 | Icn Switzerland Ag | Preparation for skin and mucous membrane |
| PT746327E (pt) * | 1994-02-21 | 2004-06-30 | Univ Aberdeen | Nitrito acidificado como um agente antimicrobiano |
-
1998
- 1998-03-02 GB GBGB9804469.6A patent/GB9804469D0/en not_active Ceased
-
1999
- 1999-03-01 CN CNB998035866A patent/CN1270725C/zh not_active Expired - Fee Related
- 1999-03-01 HU HU0101374A patent/HUP0101374A3/hu unknown
- 1999-03-01 WO PCT/GB1999/000605 patent/WO1999044622A1/en not_active Application Discontinuation
- 1999-03-01 CA CA002322199A patent/CA2322199A1/en not_active Abandoned
- 1999-03-01 PL PL99342755A patent/PL342755A1/xx not_active Application Discontinuation
- 1999-03-01 BR BR9908617-4A patent/BR9908617A/pt not_active Application Discontinuation
- 1999-03-01 NZ NZ506678A patent/NZ506678A/xx unknown
- 1999-03-01 MX MXPA00008583A patent/MXPA00008583A/es not_active Application Discontinuation
- 1999-03-01 KR KR1020007009698A patent/KR20010041527A/ko not_active Application Discontinuation
- 1999-03-01 EP EP99937878A patent/EP1059928A1/en not_active Ceased
- 1999-03-01 JP JP2000534223A patent/JP2002505295A/ja not_active Withdrawn
- 1999-03-01 AU AU32617/99A patent/AU758264B2/en not_active Ceased
-
2000
- 2000-08-29 NO NO20004302A patent/NO20004302L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2322199A1 (en) | 1999-09-10 |
| HUP0101374A3 (en) | 2003-07-28 |
| KR20010041527A (ko) | 2001-05-25 |
| JP2002505295A (ja) | 2002-02-19 |
| NZ506678A (en) | 2003-04-29 |
| NO20004302L (no) | 2000-10-30 |
| MXPA00008583A (es) | 2003-07-14 |
| PL342755A1 (en) | 2001-07-02 |
| GB9804469D0 (en) | 1998-04-29 |
| CN1291897A (zh) | 2001-04-18 |
| AU3261799A (en) | 1999-09-20 |
| HUP0101374A2 (hu) | 2001-08-28 |
| AU758264B2 (en) | 2003-03-20 |
| WO1999044622A1 (en) | 1999-09-10 |
| CN1270725C (zh) | 2006-08-23 |
| EP1059928A1 (en) | 2000-12-20 |
| NO20004302D0 (no) | 2000-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9908617A (pt) | Nitroto inorgânico e ácido orgânico em combinação como uma composição antiviral tópica. | |
| BR0011116A (pt) | Usos de uma nsaid que libera no como um sal farmaceuticamente aceitável ou um enanciÈmero do mesmo, e de uma nsaid que libera no e de um inibidor de bomba de próton suscetìvel a ácido ou um sal do mesmo ou um enanciÈmero ou de um sal do enanciÈmero, método para o tratamento de uma infecção bacteriana, e, formulação farmacêutica adequada para uso no tratamento de infecções bacterianas | |
| BRPI0611400B8 (pt) | formulações contendo xiloglicano muco-adesivas úteis em dispositivos médicos e em formulações farmacêuticas | |
| ES2949139T3 (es) | Composición que elimina la congestión nasal y que tiene actividad antivírica | |
| BR0108730A (pt) | Sistema, dispositivo e método para administração de uma droga, bocal de um dispositivo de administração de droga, dispositivo para administração de doses unitárias múltiplas de uma droga, métodos para preparação de um sistema de administração de droga e de uma formulação de droga e para tratamento de um paciente que necessita de doses múltiplas de uma droga, formulação de droga e multiparticulados | |
| IL139231A0 (en) | Preparations for the application of anti-inflammatory, especially antiseptic, agents and/or agents promoting the healing of wounds to the lower respiratory tract | |
| BRPI0513200A (pt) | uso de um anticorpo anti-igf-1r na preparação de um medicamento para tratamento combinado para malignidades não-hematológicas | |
| BR0112356A (pt) | Formulações farmacêuticas tópicas e métodos de tratamento | |
| BR0014512A (pt) | Tratamento tópico para infecções por estreptococos | |
| BR9715022A (pt) | Método para tratar de doenças prostáticas usando formulações de vitamina d por liberação sistemática e/ou prolongada | |
| CY1110078T1 (el) | Παρασκευασματα με ιωδιουχο ποβιδονη για την αγωγη τραυματων | |
| BR0108074A (pt) | Medicamento útil para tratamento de inflamações assépticas, uso dele, método para a preparação do mesmo, método para tratamento de inflamações assépticas, e, toalha úmida útil para tratamento de inflamações assépttcas | |
| KR20110063434A (ko) | 국소 항염증 조합물 | |
| BR0010983A (pt) | Preparações para a aplicação de agentes antiinflamatórios | |
| BR0213248A (pt) | Formulação farmacêutica, dose farmacêutica, dispersão sólida de um polìmero entérico, métodos para o tratamento de cãncer de próstata e/ou para a redução do risco de cancer de próstata em um paciente, para aumentara biodisponibilidade e a estabilidade em armazenamento de 4'-ciano-alfa',alfa',alfa' -trifluoro-3-(4-fluorofenilsilfonil)-2-hidróxi-2-metil propiono-m-toluidida, e para a preparação de uma formulação farmacêutica, e, usos de 4'-ciano-alfa',alfa',alfa'-trifluoro-3-(4-fluorofenilsu lfonil -2-hidróxi-2-metilpropiono-m-toluidida e de um polìmero entérico | |
| BR0207866A (pt) | Uso de flumazenil na preparação de um medicamento para o tratamento da dependência de cocaìna | |
| AR029189A1 (es) | Uso de un inhibidor de fosfodiesterasa 4 y un corticoesteroide antiinflamatorio en forma combinada, separadamente o separadamente secuencial para la preparacion de un medicamento | |
| KR920703060A (ko) | 제약학적 배합물 | |
| KR910004186A (ko) | 제약학적 배합물 | |
| BR0316973A (pt) | Uso de ácido docosahexanóico como substância ativa para o tratamento de lipodistrofia | |
| AR010432A1 (es) | Composiciones farmaceuticas que contienen acido ricinoleico y su uso para la terapia antiinflamatoria y analgesica | |
| Baba et al. | Resolution of cutaneous lesions of granuloma annulare by intralesional injection of human fibroblast interferon | |
| PT100670A (pt) | Formulacoes farmaceuticas topicas de oleo-em -agua ou aquosa para o tratamento de infeccoes virais | |
| JPS6483024A (en) | Cataplasm for cold | |
| WO2001045727A3 (en) | Stabilized veterinary compositions comprising more than one antiviral agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI |